Resources

Current and New Treatments for Diabetes 2019

Research Objectives:

  • Understand patient characteristics and current treatments for Type 2 Diabetes
  • Explore what physicians need for future Type 2 Diabetes treatment and what they are most excited about

Methodology:
Method: 5-minute MicroSurvey via InCrowd
Crowds: US Endocrinologists, US Primary Care Physicians
Sample Size: n=85
Fielding Period: May 30, 2019
Screening Criteria: Qualified respondents are US-based endocrinologists and PCPs who treat at least 20 Type 2 Diabetes (T2D) patients in a typical month.

One key finding:

  • In terms of future developments, physicians are excited about several new options including oral GLP-1 RAs, new medication options with less frequent dosing, and enhanced diabetes management devices.

Download the full report now!

Please fill out the form below to access this content

Related Resources

IV Fluid Supply Chain Disruptions 

IV Fluid Supply Chain Disruptions 

Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has...

read more
Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more
ASH 2023 Post-Event Round-Up 

ASH 2023 Post-Event Round-Up 

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...

read more